As TP53 appears to modulate both iron metabolism and ferroptosis, a comprehensive understanding of TP53 in modulating ferroptosis needs to be further elucidated, which is required to target pancreatic cancer as a therapeutic strategy. The gene discussed is TP53; the disease is familial pancreatic carcinoma.